Joseph Jankovic
Baylor St. Luke's Medical Center · Baylor College of Medicine · Houston, Texas
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Joseph Jankovic as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:02 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04871451 · Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical DystoniaAEON Biopharma, Inc. · completed · Cervical Dystonia · principal investigator
- Ph2NCT04849988 · A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical DystoniaAEON Biopharma, Inc. · completed · Cervical Dystonia · principal investigator
- N/ANCT01337453 · Flu-Like Symptoms as a Complication of Botulinum Toxin TherapyChristine Hunter · completed · Flu-like Symptoms · principal investigator
- Early Ph1NCT00646451 · Pregabalin in the Treatment of Essential TremorBaylor College of Medicine · completed · Essential Tremor · principal investigator
- Ph3NCT00406367 · IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of BlepharospasmMerz Pharmaceuticals GmbH · completed · Blepharospasm · study chair
- Ph3NCT00206336 · An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.Baylor College of Medicine · completed · Tourette Syndrome · principal investigator
- Ph3NCT00206323 · A Randomized, Placebo-controlled, Tourette Syndrome Study.Baylor College of Medicine · completed · Tourette Syndrome · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Clinical center for the study of neuroprotection from PDU10NS044441 · NINDS · BAYLOR COLLEGE OF MEDICINE · fiscal years 2008 to 2013 · $48,249 awarded in 2013Same name and institution; not confirmed by an ID
- DEPRENYL AND TOCOPHEROL ANTIOXIDATIVE THERAPY OF PARKINSONISMM01RR000350 · NCRR · BAYLOR COLLEGE OF MEDICINE · fiscal years 1985 to 1992Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:02 UTC. The ranking covers the 200 most relevant of 109 PubMed records, and a shared surname and initials can bring in a namesake. All 109 on PubMed
- Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.Neurology · 2003653 citationsRCR 15.5
- A double-blind, delayed-start trial of rasagiline in Parkinson's disease.N Engl J Med · 2009623 citationsRCR 18.7
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.Lancet Neurol · 2010516 citationsRCR 13.6
- Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.Arch Neurol · 2004432 citationsRCR 12.6
- 414 citationsRCR 13.0
- Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study.Neurology · 1987356 citationsRCR 18.1
- Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial.Lancet Neurol · 2012322 citationsRCR 12.7
- Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine.Am J Med · 1993275 citationsRCR 10.5
- Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.Neurology · 1999259 citationsRCR 10.3
- 253 citationsRCR 10.5